AGA clinical practice update: De-prescribing PPIs reduces costs, risks for adverse events

The AGA has issued a clinical practice update on de-prescribing proton pump inhibitors, according to an article in Gastroenterology.
“Although PPIs are the treatment of choice for the management of acid-mediated upper gastrointestinal conditions, these agents are being used increasingly for less clear indications and for indeterminate durations,” Laura E. Targownik, MD, MSHS, a gastroenterologist at Mount Sinai Hospital and associate professor of gastroenterology and hepatology at the University of Toronto, and colleagues wrote. “As PPI use has become more common, the

The AGA has issued a clinical practice update on de-prescribing proton pump inhibitors, according to an article in Gastroenterology.
“Although PPIs are the treatment of choice for the management of acid-mediated upper gastrointestinal conditions, these agents are being used increasingly for less clear indications and for indeterminate durations,” Laura E. Targownik, MD, MSHS, a gastroenterologist at Mount Sinai Hospital and associate professor of gastroenterology and hepatology at the University of Toronto, and colleagues wrote. “As PPI use has become more common, the